Earnings call transcript: Piaggio & C sees mixed Q1 2026 performance

Piaggio’s Q1 2026 net sales fell 7.8% year over year, mainly due to foreign exchange headwinds, even as gross margin improved to 31.6% from 30% and cash absorption dropped to EUR 19 million from EUR 58 million. Management said underlying EBIT was roughly flat excluding about EUR 3 million of one-offs from U.S. tariffs and India land depreciation, and reaffirmed a 30%-35% gross margin target. Shares fell 3.99% to EUR 1.705 after the release, while Q2 is expected to benefit from Aprilia SR GT 400, new Vespa launches, and double-digit April volume growth.

Analysis

The market is punishing the wrong line item. FX and tariffs are masking a business that still appears to be holding price/mix and taking share in core geographies; that usually matters more for medium-term equity value than a single quarter of top-line translation noise. The bigger signal is that management is explicitly choosing not to chase volume in Europe ahead of new launches, which should protect dealer economics and reduce channel stuffing risk into Q2.

The second-order winner is the product cycle itself: a clean launch window into Q2 can convert what looks like deferred demand into a sharper-than-normal sell-in rebound, especially if early April data is already tracking double-digit growth. That creates a favorable setup for margin expansion because incremental units should carry better mix than the old base, while the company is simultaneously showing better working-capital discipline. The risk is that this is still a very consumer-discretionary, FX-sensitive franchise, so if the dollar reverses less of a headwind and tariffs persist, the operating leverage can swing back quickly.

Consensus likely underestimates how much of the current gap is self-inflicted optics rather than demand destruction. The stock is vulnerable near term because investors will focus on reported revenue, but the combination of stable gross margin, lower cash absorption, and visible new SKUs argues for a rerating once launch data lands. In other words, this is more of a timing mismatch than a broken story, and the market may be pricing an earnings dip that should partially normalize over the next 1-2 quarters.

Key Decisions for Investors

• Long 0FM1 on a 1-3 month horizon into Q2 launch data: risk/reward favors buying weakness if April strength persists; use a tight stop below the post-earnings low because the thesis breaks if sell-in fails to accelerate.
• Pair trade: long 0FM1 / short a higher-multiple consumer cyclical with similar Europe exposure for the next 6-8 weeks; the idea is to isolate product-cycle upside while hedging macro and FX noise.
• Sell downside volatility in 0FM1 via June put spreads if liquidity allows: near-term reaction is driven by headline optics, but management has given a credible catalyst path that should compress implied downside unless Q2 disappoints.
• If seeking direct EM exposure, prefer 0FM1 over pure-play industrial exporters that lack pricing power; this name offers FX-translated headwinds today but better self-help from mix and launch cadence over the next quarter.